Visual Outcomes of Tecnis Symfony Opti-Blue EDOF Intraocular Lens (IOL)
Starting soon · Not applicable
Conditions studied: Cataract
In brief
Tecnis Symfony Optiblue EDOF IOL is the latest version of Tecnis Symfony IOL with a violet light filter (VLF), which blocks short-wavelength light and improves the quality of vision while minimizing visual disturbances. The present study aims to assess the visual outcomes at distance, intermediate, and near following cataract surgery and implantation of Tecnis Symfony Optiblue IOL in patients with retinal comorbidities.
Key facts
- Study ID
- NCT06500416
- Run by
- Coastal Eye Surgeons PLLC
- People needed
- 15
- Starts
- 2024-08-01
- Expected to finish
- 2026-01-01
- Last updated by the study team
- 2024-08-09
Who can join
Age: 50 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients diagnosed with retinal comorbidities, with visual acuity potential of 20/30 or better, who wish to undergo bilateral cataract surgery and are willing to provide written informed consent and adhere to study requirements.
You may not qualify if…
- Corneal dystrophies
- Central corneal scarring
- Keratoconus
- Proliferative diabetic retinopathy
- Exudative macular degeneration
- Zonular weakness
- Pseudoexfoliation
- Fovea-involving atrophy
- Severe dry eye
- Amblyopia
- Pupil abnormalities
- Need for an IOL outside the range of +5.0 D to +34.0 D or cylinder power over 3.75 D
- Patients who have undergone prior cataract surgery and IOL implantation in either eye; had prior corneal refractive or corneal transplantation surgery; diabetics post-vitrectomy; or who have a history of macula-off retinal detachment will also be excluded.
Where it is running
- Coastal eye surgeons — Greenwich, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.